These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19585842)

  • 21. Cost of preventive drugs. Dare to tell?
    Trewby PN
    BMJ; 2011 May; 342():d3198. PubMed ID: 21610062
    [No Abstract]   [Full Text] [Related]  

  • 22. The true cost of pharmacological disease prevention.
    Järvinen TL; Sievänen H; Kannus P; Jokihaara J; Khan KM
    BMJ; 2011 Apr; 342():d2175. PubMed ID: 21505222
    [No Abstract]   [Full Text] [Related]  

  • 23. The price of success: cost-effectiveness of molecularly targeted agents.
    Sleijfer S; Verweij J
    Clin Pharmacol Ther; 2009 Feb; 85(2):136-8. PubMed ID: 19151639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 340B program presents opportunities--and challenges.
    Keough CL; Webster SA
    Healthc Financ Manage; 2009 Nov; 63(11):42-4, 46, 48. PubMed ID: 19891397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness data on biologics needed.
    Sheridan C; Katsnelson A
    Nat Biotechnol; 2005 Mar; 23(3):272-3. PubMed ID: 15765069
    [No Abstract]   [Full Text] [Related]  

  • 26. The 340B Drug Pricing Program: an opportunity for savings, if covered entities such as disproportionate share hospitals and federally qualified health centers know how to interpret the regulations.
    Werling K; Abraham S; Strelec J
    J Health Care Finance; 2007; 34(2):57-70. PubMed ID: 18972994
    [No Abstract]   [Full Text] [Related]  

  • 27. [The cost of innovative drugs].
    Reggio S
    Recenti Prog Med; 1999; 90(7-8):371-2. PubMed ID: 10429514
    [No Abstract]   [Full Text] [Related]  

  • 28. How NICE may be outflanked.
    Ferner RE; McDowell SE
    BMJ; 2006 May; 332(7552):1268-71. PubMed ID: 16735342
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacogenetics.
    Noah L
    N Engl J Med; 2003 May; 348(20):2041-3; author reply 2041-3. PubMed ID: 12751475
    [No Abstract]   [Full Text] [Related]  

  • 31. Sir Michael Rawlins on being NICE--and fair--about drug development and availability. Interview by Daniel Clarke.
    Rawlins SM
    Drug Discov Today; 2005 Mar; 10(6):383-6. PubMed ID: 15808816
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical trials and health economics--a marriage of convenience or a marriage made in heaven?
    Bakhai A; Greenberg D
    J Med Econ; 2008; 11(3):541-6. PubMed ID: 19450103
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug plundering].
    Velásquez G
    Assist Inferm Ric; 2003; 22(3):182-4. PubMed ID: 14666857
    [No Abstract]   [Full Text] [Related]  

  • 34. What's driving up health insurance cost now?
    Batterson RE
    Tex Dent J; 2003 Mar; 120(3):288-91. PubMed ID: 12723113
    [No Abstract]   [Full Text] [Related]  

  • 35. Spiraling drug costs: a call for cost-effective prescribing.
    Good CB
    J Am Geriatr Soc; 2005 Aug; 53(8):1427-9. PubMed ID: 16078975
    [No Abstract]   [Full Text] [Related]  

  • 36. Priced out of the UK market.
    Moran N
    Nat Biotechnol; 2008 Feb; 26(2):151-4. PubMed ID: 18259163
    [No Abstract]   [Full Text] [Related]  

  • 37. [TLV meets criticism: costs of antihypertensive agents can and should be reduced].
    Edling A; Löfmark R; Vinge E; Carlsson P; André M; Melltorp G; Edhag O; Dahlqvist R; Andersson I; Magnusson D
    Lakartidningen; 2008 Sep 17-23; 105(38):2592-3. PubMed ID: 18846865
    [No Abstract]   [Full Text] [Related]  

  • 38. [Can drug consumption in general be reduced and can drug costs for insurance carriers be reduced?].
    TOELKE S
    Pharm Prax; 1959; 10():149-53. PubMed ID: 13838637
    [No Abstract]   [Full Text] [Related]  

  • 39. [Can we decrease pharmacy costs?].
    Azagra Ledesma R
    Aten Primaria; 1993 Feb; 11(3):117-8. PubMed ID: 8453001
    [No Abstract]   [Full Text] [Related]  

  • 40. "Who's winning the human race?"Cold war as pharmaceutical political strategy.
    Tobbell DA
    J Hist Med Allied Sci; 2009 Oct; 64(4):429-73. PubMed ID: 19493917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.